SG/CALL/ABBOTT LABORATORIES/120/0.1/21.03.25 Stock

Warrant

DE000SW3PQ01

Delayed Deutsche Boerse AG 03:08:22 2024-07-05 pm EDT
0.3 EUR +15.38% Intraday chart for SG/CALL/ABBOTT LABORATORIES/120/0.1/21.03.25
Current month-16.13%
1 month-16.13%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-05 0.3 +15.38%
24-07-04 0.26 -3.70%
24-07-03 0.27 -10.00%
24-07-02 0.3 +3.45%
24-07-01 0.29 -6.45%

Delayed Quote Deutsche Boerse AG

Last update July 05, 2024 at 03:08 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Société Générale Société Générale
WKN SW3PQ0
ISINDE000SW3PQ01
Date issued 2023-09-19
Strike 120 $
Maturity 2025-03-21 (259 Days)
Parity 10 : 1
Emission price 0.67
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.36
Lowest since issue 0.24
Spread 0.01
Spread %3.23%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
102.3 USD
Average target price
124.9 USD
Spread / Average Target
+22.08%
Consensus